Trials / Recruiting
RecruitingNCT06930976
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within the cell. Investigators will intravenously infuse a non-radioactive glucose tracer into participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 13C6-Glucose | Compounded as 5% 13C6-Glucose in sterile water given IV over 2-4 hours as a split bolus and infusion |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2025-04-16
- Last updated
- 2025-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06930976. Inclusion in this directory is not an endorsement.